CAS 440124-96-9

Efavirenz Related Compound B ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one)

CAS : 440124-96-9

Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi

Formule : C₁₄H₁₁ClF₃NO₂

Couleur et forme : White Powder

Masse moléculaire : 317.04304

Ref: 45-1234147

Efavirenz USP Related Compound B

CAS : 440124-96-9

Formule : C₁₄H₁₁ClF₃NO₂

Couleur et forme : White To Off-White Solid

Masse moléculaire : 317.69

Ref: 4Z-E-074

(E)-Dihydro Efavirenz

CAS : 440124-96-9

Impurity Efavirenz USP Related Compound B
Applications (E)-Dihydro Efavirenz (Efavirenz USP Related Compound B) is an impurity of the nonnucleoside HIV-1 reverse transcriptase inhibitor Efavirenz (E425000).
References Weissburg, R.P. et al.: J. Pharmac. Biomed. Anal., 28, 45 (2002); Ribeiro, J.A.A. et al.: J. Pharmac. Biomed. Anal., 43, 298 (2007);

Formule : C₁₄H₁₁ClF₃NO₂

Couleur et forme : Neat

Masse moléculaire : 317.69

Ref: TR-D448935

(4S)-6-Chloro-4-[(1E)-2-cyclopropylethenyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one

CAS : 440124-96-9

Efavirenz is a non-nucleoside reverse transcriptase inhibitor. It is used to treat HIV infection and AIDS. Efavirenz has been shown to be an impurity in the synthesis of 6-chloro-4-[(1E)-2-cyclopropylethenyl]-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one. The impurities are removed by a deprotection reaction that removes the protecting group from the molecule.

Formule : C₁₄H₁₁ClF₃NO₂

Degré de pureté : Min. 95%

Masse moléculaire : 317.69 g/mol

Ref: 3D-FC102842